Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

    Virtual Booth

    Contact Supplier

    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    China

    Virtual Booth

    Contact Supplier

    Menu

    Alilestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,857Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants interchangeability to Samsung & Organon Hadlima Inj
    FDA Grants interchangeability to Samsung & Organon Hadlima Inj

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527970852/en/US-Food-and-Drug-Administration-FDA-Grants-Interchangeability-Designation-to-Samsung-Bioepis-and-Organon-HADLIMA-adalimumab-bwwd-Injection

    BUSINESSWIRE
    27 May 2025
    Share Share
    Organon taps into 'romantasy' craze with new Nexplanon ad
    Organon taps into 'romantasy' craze with new Nexplanon ad

    13 May 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/organon-taps-romantasy-craze-new-nexplanon-ad

    FIERCE PHARMA
    13 May 2025
    Share Share
    Organon Reports Q1 Results Ended March 31, 2025
    Organon Reports Q1 Results Ended March 31, 2025

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501009397/en/Organon-Reports-Results-for-the-First-Quarter-Ended-March-31-2025

    BUSINESSWIRE
    01 May 2025
    Share Share
    Organon Appoints Ramona A. Sequeira to Board of Directors
    Organon Appoints Ramona A. Sequeira to Board of Directors

    15 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415558806/en/Organon-Appoints-Ramona-A.-Sequeira-to-the-Companys-Board-of-Directors

    BUSINESSWIRE
    15 Apr 2025
    Share Share
    Organon to Report Q1 2025 Results, Host Conference Call on May 1
    Organon to Report Q1 2025 Results, Host Conference Call on May 1

    15 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415758908/en/Organon-To-Report-First-Quarter-2025-Results-and-Host-Conference-Call-on-May-1-2025

    BUSINESSWIRE
    15 Apr 2025
    Share Share
    Organon Acquires Tofidence, a Biosimilar to Actemra in US
    Organon Acquires Tofidence, a Biosimilar to Actemra in US

    01 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250331812163/en/Organon-Acquires-TOFIDENCE-tocilizumab-bavi-a-Commercialized-Biosimilar-to-ACTEMRA-tocilizumab-Injection-for-Intravenous-Infusion-in-the-U.S.

    BUSINESSWIRE
    01 Apr 2025
    Share Share